COXANTO Drug Patent Profile
✉ Email this page to a colleague
When do Coxanto patents expire, and when can generic versions of Coxanto launch?
Coxanto is a drug marketed by Solubiomix and is included in one NDA.
The generic ingredient in COXANTO is oxaprozin. There are thirteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Coxanto
A generic version of COXANTO was approved as oxaprozin by DR REDDYS LABS LTD on January 31st, 2001.
Summary for COXANTO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in COXANTO? | COXANTO excipients list |
| DailyMed Link: | COXANTO at DailyMed |
Pharmacology for COXANTO
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for COXANTO
US Patents and Regulatory Information for COXANTO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solubiomix | COXANTO | oxaprozin | CAPSULE;ORAL | 217927-001 | Oct 20, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
